NYSE:PFE Stock Quote
25.01
-0.20 (-0.79%)
Pfizer is a global biopharmaceutical company that develops and manufactures innovative medicines and vaccines to improve health outcomes for people around the world
Renowned for its extensive research and development efforts, Pfizer focuses on various therapeutic areas including vaccines, oncology, immunology, cardiology, endocrinology, and rare diseases. The company is committed to addressing significant health challenges through the discovery of new treatments, leveraging cutting-edge science and technology. Pfizer also emphasizes partnerships and collaborations to expand its capabilities and enhance access to healthcare solutions.
Previous Close | 25.21 |
---|---|
Open | 25.20 |
Bid | 25.04 |
Ask | 25.06 |
Day's Range | 24.83 - 25.23 |
52 Week Range | 24.48 - 31.54 |
Volume | 51,302,102 |
Market Cap | 140.22B |
PE Ratio (TTM) | 17.74 |
EPS (TTM) | 1.4 |
Dividend & Yield | 1.680 (6.72%) |
1 Month Average Volume | 55,612,297 |
News & Press Releases
Blue-chip stocks are established, financially strong, and consistently profitable publicly traded companies.
Via Talk Markets · March 27, 2025
Looking for the most active stocks in the S&P500 index on Thursday? Dive into today's session and discover the stocks that are dominating the trading activity and setting the pace for the market.
Via Chartmill · March 27, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · March 27, 2025
GEO-CM04S1 BARDA/Project NextGen Phase 2b trial preparations ongoing with manufacturing of clinical trial materials underway and clinical sites confirmed
Via TheNewswire.com · March 27, 2025
Genmab's Tivdak wins Japan's approval for advanced cervical cancer after a Phase 3 trial showed improved survival over chemotherapy.
Via Benzinga · March 27, 2025
As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the branded pharmaceuticals industry, including Pfizer (NYSE:PFE) and its peers.
Via StockStory · March 27, 2025
Pfizer shares are trading lower Wednesday after a Wall Street Journal report revealed that U.S. prosecutors are investigating a claim about the timing of Pfizer's COVID-19 vaccine announcement.
Via Benzinga · March 26, 2025
Stay informed about the most active S&P500 stocks in today's session as we take a closer look at what's happening on the US markets on Wednesday. Discover the stocks that are generating the highest trading volume and driving market activity.
Via Chartmill · March 26, 2025
Exelixis' Cabometyx gains FDA approval for advanced neuroendocrine tumors, while phase 3 data confirms sustained survival benefits in renal cancer.
Via Benzinga · March 26, 2025
Curious about the most active S&P500 stocks in today's session? Get insights into the stocks that are leading the way in terms of trading volume and market attention.
Via Chartmill · March 25, 2025
China is stepping up efforts to reassure U.S. corporate giants like Apple, Pfizer, and Mastercard of its economic potential, with Vice Premier He Lifeng promising a better business environment amid rising U.S. tariff pressures and slowing foreign investment.
Via Benzinga · March 23, 2025
Via The Motley Fool · March 22, 2025
Via Benzinga · March 21, 2025
Adeep dive into Merck and Pfizer, two of the biggest pharmaceutical companies out there.
Via Talk Markets · March 21, 2025
UK pharma leaders warn excessive NHS levies threaten industry growth, urging the government to reform payments. The ABPI highlights declining UK R&D investment and falling global competitiveness.
Via Benzinga · March 21, 2025
Alnylam added a gene silencer to the cardiomyopathy space this week, and will now rival Pfizer and BridgeBio.
Via Investor's Business Daily · March 21, 2025
Investors are often driven by the pursuit of massive gains and few assets capture this ambition better than individual stocks–like Nvidia Corporation (NASDAQ:
Via Benzinga · March 20, 2025
Via The Motley Fool · March 20, 2025
Via The Motley Fool · March 20, 2025
Via The Motley Fool · March 20, 2025
Curious about the most active S&P500 stocks in today's session? Get insights into the stocks that are leading the way in terms of trading volume and market attention.
Via Chartmill · March 19, 2025
Pfizer has completed its exit from Haleon, selling its entire stake for $3.1 billion. BlackRock's unit is now Haleon's largest shareholder with over 5%.
Via Benzinga · March 19, 2025